New memory test could spot Alzheimer's earlier

NCT ID NCT06564779

Recruiting now Diagnosis Sponsor: University Hospital, Tours Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new memory assessment tool called NEM (New evaluation of Episodic Memory) to see if it can better diagnose Alzheimer's disease in people with mild memory problems. Researchers will compare the NEM test with standard memory tests in 150 adults aged 50 and older who have amnestic mild cognitive impairment. The goal is to improve early and accurate diagnosis of Alzheimer's.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could provide a more accurate and sensitive way to diagnose Alzheimer's disease earlier, helping patients and doctors plan care sooner.
What could go wrong: This is an early-stage study with only 150 participants, so results may not apply to everyone. The new test may not prove better than existing memory assessments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MEMORY DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cognitive disorder Memory Disorders

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MEMORY DISORDERS

Contacts and locations

Locations

University hospital
RECRUITING

Tours, 37044, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.